UCSB Acquisition, a blank check company led by Chinese executives, filed on Friday with the SEC to raise up to $60 million in ...

Aspen Neuroscience, a Phase 1/2a biotech developing stem cell therapies for Parkinson’s disease, announced terms for its IPO ...

However, the week’s most notable news came from Anthropic (ANT), which filed its long awaited S-1 on Monday for an IPO that could be the largest ever. Immunology and inflammation biotech Bambusa ...

Just one SPAC is currently scheduled to list in the week ahead, although some smaller deals may also join the calendar ...

Redwoods Acquisition II, a blank check company targeting the energy storage, telecom, and consumer sectors, filed on Thursday ...

BHAV Acquisition II, a blank check company targeting robotics, EVs, fintech, advanced computing and energy tech, raised $100 ...

Tracx Logis, a Singapore-based logistics provider focused on cross-border services, lowered the proposed deal size for its ...

Med-X, which manufactures natural pesticides and other green products under various brands, increased the number of shares to ...

Lycia Therapeutics, a Phase 1 biotech developing protein degraders for food allergy and Graves' disease, announced terms for ...

Gravitics Holdings, which develops space structures and orbital systems, lowered the proposed deal size for its upcoming IPO ...

Heroic Empire Acquisition, a blank check company targeting AI, biotech, energy, and advanced manufacturing, filed on Tuesday ...

Africa-linked IPOs are having a strong year. Seven companies with significant African operations have raised at least $100 ...